Published: Oct 14, 2021
AstraZeneca’s COVID-19 vaccine manufactured in Thailand has been authorised under the World Health Organization (WHO) Emergency Use Listing (EUL) procedure, with immediate effect.
Published: Oct 12, 2021
Positive high-level results from the TACKLE Phase III COVID-19 treatment trial showed AstraZenecas AZD7442, a long-acting antibody (LAAB) combination, achieved a statistically significant reduction in severe COVID-19 or death compared to placebo in non-hospitalised patients with mild-to-moderate symptomatic COVID-19.
Published: Oct 07, 2021
The Department of Disease Control (DDC) is planning to propose the use of an AstraZeneca-Pfizer cocktail for general use at its next meeting with the Immunisation Subcommitee, DDC director-general Dr Opas Karnkawinpong said.
Published: Sep 23, 2021
The Department of Medical Sciences said on Wednesday that research shows an intradermal (ID) delivery of the Covid-19 vaccine uses a significantly small amount of the dose and achieves the same result as traditional intramuscular (IM) vaccination.